|
End-of-day quote
Ghana S.E.
|
||
| - GHS | - |
|
| Market Cap | 5.2M 59.51M 4.5M 4.25M 3.85M 7.23M 498M 7.28M 50.75M 19.55M 253M 19.52M 19.09M 803M | P/E 2017 |
11.7x | P/E 2018 | 6.9x |
|---|---|---|---|---|---|
| Enterprise Value | 10.45M 120M 9.05M 8.54M 7.75M 14.54M 1B 14.64M 102M 39.31M 508M 39.23M 38.37M 1.61B | EV / Sales 2017 |
1.34x | EV / Sales 2018 | 1.05x |
| Free-Float |
26.89% | Yield 2017 * |
-
| Yield 2018 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | 0.00% | - | - | 915K | ||
| +2.02% | -0.96% | +50.69% | +92.40% | 994B | ||
| +0.28% | -3.24% | +49.57% | +62.65% | 640B | ||
| +1.81% | +2.07% | +19.89% | +70.38% | 454B | ||
| +5.00% | +2.21% | +36.64% | +39.24% | 337B | ||
| +1.68% | -9.20% | +15.25% | +24.87% | 261B | ||
| +3.81% | +0.93% | +3.05% | +12.39% | 246B | ||
| +1.10% | -12.75% | +38.03% | +45.44% | 204B | ||
| +1.43% | -6.21% | -19.49% | -58.94% | 190B | ||
| +1.87% | -3.04% | +27.81% | +89.26% | 178B | ||
| Average | +2.00% | -4.63% | +24.60% | +41.97% | 350.48B | |
| Weighted average by Cap. | +1.60% | -3.19% | +33.46% | +57.27% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | 8.89M 102M 7.71M 7.27M 6.6M 12.38M 852M 12.46M 86.85M 33.46M 432M 33.4M 32.66M 1.37B | 9.91M 113M 8.59M 8.1M 7.35M 13.79M 950M 13.89M 96.78M 37.29M 482M 37.22M 36.4M 1.53B |
| Net income | 665K 7.62M 576K 544K 493K 925K 63.74M 932K 6.49M 2.5M 32.34M 2.5M 2.44M 103M | 762K 8.72M 660K 623K 565K 1.06M 72.99M 1.07M 7.44M 2.87M 37.03M 2.86M 2.8M 118M |
| Net Debt | 4.15M 47.49M 3.59M 3.39M 3.08M 5.77M 397M 5.81M 40.5M 15.61M 202M 15.58M 15.23M 641M | 5.25M 60.12M 4.55M 4.29M 3.89M 7.31M 503M 7.36M 51.27M 19.76M 255M 19.72M 19.28M 812M |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- SPL Stock
Select your edition
All financial news and data tailored to specific country editions
















